Pascual J et al. |
Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. |
2006 |
Transplantation |
pmid:16861942
|
Kuypers DR et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements. |
2010 |
Transplantation |
pmid:20555228
|
Rodrigo E et al. |
Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development. |
2016 |
Transplantation |
pmid:26703349
|
Sheikh AM et al. |
Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. |
1999 |
Transplantation |
pmid:10440408
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. |
1997 |
Transplantation |
pmid:9326428
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
Tze WJ et al. |
In vitro effects of FK-506 on human and rat islets. |
1990 |
Transplantation |
pmid:1694319
|
de Graav GN et al. |
A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation. |
2017 |
Transplantation |
pmid:28403127
|
Shapiro R et al. |
Pediatric renal transplantation under tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10075598
|
Hoogtanders K et al. |
Dried blood spot measurement of tacrolimus is promising for patient monitoring. |
2007 |
Transplantation |
pmid:17264824
|
Ninova D et al. |
Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. |
2004 |
Transplantation |
pmid:15316360
|
Meier M et al. |
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. |
2006 |
Transplantation |
pmid:16612281
|
McLaren A |
Tacrolimus pharmacogenetics: bringing the laboratory into the clinic. |
2003 |
Transplantation |
pmid:14705621
|
Roberts CA et al. |
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. |
2002 |
Transplantation |
pmid:12364862
|
Vincenti F et al. |
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. |
2002 |
Transplantation |
pmid:11907427
|
McCarthy SA et al. |
The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. |
1992 |
Transplantation |
pmid:1384186
|
Wennberg L et al. |
Preapheresis immunosuppressive induction: necessary or harmful? |
2007 |
Transplantation |
pmid:18162987
|
Holman MJ et al. |
FK506-associated thrombotic thrombocytopenic purpura. |
1993 |
Transplantation |
pmid:7678357
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Rayar M et al. |
High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes. |
2018 |
Transplantation |
pmid:29315140
|